
- Oncology NEWS International Vol 6 No 11
- Volume 6
- Issue 11
Federation of European Cancer Societies Sponsors Biennial ECCO
HAMBURG-More than 6,000 cancer researchers, clinical oncologists, and specialist cancer nurses from all over the world attended the Ninth European Cancer Conference (ECCO 9), considered Europe’s foremost multidisciplinary oncology event. (See reports on pages 1, 2, 3, 8, 13, 15, 24, 27, and 40.)
HAMBURGMore than 6,000 cancer researchers, clinical oncologists, and specialist cancer nurses from all over the world attended the Ninth European Cancer Conference (ECCO 9), considered Europes foremost multidisciplinary oncology event. (See reports on pages 1, 2, 3, 8, 13, 15, 24, 27, and 40.)
The conference is the biennial meeting of the Federation of European Cancer Societies (FECS) (see table). Said FECS president, Professor Jean Claude Horiot: ECCO meetings give delegates the opportunity to update themselves on a range of cancer issues in one venue. They hear at first hand about advances in research and treatment often before they are published, or when they have appeared only in highly specialist journals.
Members of the Federation of European Cancer Societies (FECS)
*Affiliated member. All others are full members.
This year, for the first time, FECS has a fellowship program to help delegates from countries in Eastern Europe attend ECCO, said Professor Horiot, professor of radiotherapy, University of Dijon, France.
FECS works closely with the European Organization for Research and Treatment of Cancer (EORTC) and the European School of Oncology (ESO), and has links with the institutions of the European Union, the World Health Organizations Cancer Unit, the International Union Against Cancer (UICC), and the Association of European Cancer Leagues.
In addition to promoting and coordinating collaboration in the fields of clinical and experimental oncology throughout Europe and organizing ECCO, FECS is developing a major role in helping its full members to influence governments and other organizations involved in health care in Europe. It also is responsible for the development and coordination of continuing medical education in oncology in Europe.
Articles in this issue
almost 28 years ago
New Strategies Forecast for Pancreatic Cancer Treatmentalmost 28 years ago
Tumor Cells in Marrow Predict Cancer Outcomealmost 28 years ago
Zeneca Sponsors Rural Breast Cancer Outreachalmost 28 years ago
Private Sector Purchasers Need Cancer Care Data to Determine Qualityalmost 28 years ago
Payers May Ignore Aspects of Care Most Important to Patientsalmost 28 years ago
BCG May Be Superior to Chemotherapy in Bladder Canceralmost 28 years ago
Adjuvant Vaccine Therapy Prolongs Survival in Colon Canceralmost 28 years ago
‘Treat Low-risk Febrile Neutropenic Patients at Home’almost 28 years ago
‘Don’t Wait Too Late to Make End-of-Life Decisions’Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.